Tin tức & Cập nhật

[MK TEST DO NOT TOUCH] Annual flu jab in HF patients may lower hospitalization, pneumonia risk
[MK TEST DO NOT TOUCH] Annual flu jab in HF patients may lower hospitalization, pneumonia risk
27 Apr 2022 bởiRoshini Claire Anthony

An annual influenza vaccination does not lower the risk of cardiovascular (CV) outcomes in patients with heart failure (HF), though it may reduce the risk of pneumonia and hospitalization, according to results of the IVVE study presented at ACC.22.

[MK TEST DO NOT TOUCH] Annual flu jab in HF patients may lower hospitalization, pneumonia risk
27 Apr 2022
Hypertriglyceridemia tied with severe acute pancreatitis
Hypertriglyceridemia tied with severe acute pancreatitis
27 Apr 2022

The risk of severe acute pancreatitis appears to be significantly and independently associated with hypertriglyceridemia, reports a recent study.

Hypertriglyceridemia tied with severe acute pancreatitis
27 Apr 2022
[MK TEST DO NOT TOUCH] Novel drug helps optimize HFrEF therapy
[MK TEST DO NOT TOUCH] Novel drug helps optimize HFrEF therapy
27 Apr 2022 bởiAudrey Abella

In individuals receiving renin-angiotensin-aldosterone system inhibitor (RAASi) therapy for heart failure with reduced ejection fraction (HFrEF), the novel potassium binder patiromer effectively reduced serum potassium levels, the DIAMOND trial suggests, thus optimizing a guideline-directed RAASi therapy for these patients.

[MK TEST DO NOT TOUCH] Novel drug helps optimize HFrEF therapy
27 Apr 2022
Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer
Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer
27 Apr 2022

In patients with high-risk or unfavourable nonmetastatic prostate cancer (nmPC) receiving local definite therapy, the intensification of systemic therapy using chemotherapy or an androgen receptor signaling inhibitor (ARSI), in combination with androgen deprivation therapy (ADT), leads to better oncologic survival measures, reports a recent meta-analysis.

Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer
27 Apr 2022